{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:31:20Z","timestamp":1787729480308,"version":"build-2784847793"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jsat.2020.108219","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T02:01:15Z","timestamp":1606960875000},"page":"108219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19"],"prefix":"10.1016","volume":"122","author":[{"given":"Giliane","family":"Joseph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Torres-Lockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa R.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela A.","family":"Mund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Nahvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2020.108219_bb0005","author":"New York City Department of Health and Mental Hygiene"},{"key":"10.1016\/j.jsat.2020.108219_bb0010","article-title":"Unintentional drug poisoning (overdose) deaths in New York City in 2018. New York City Department of Health and Mental Hygiene:","volume":"116","author":"Nolan","year":"2019","journal-title":"Epi Data Brief"},{"issue":"4","key":"10.1016\/j.jsat.2020.108219_bb0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/13814788.2014.905912","article-title":"Methadone-maintained patients in primary care have higher rates of chronic disease and multimorbidity, and use health services more intensively than matched controls","volume":"20","author":"O\u2019Toole","year":"2014","journal-title":"European Journal of General Practice"},{"key":"10.1016\/j.jsat.2020.108219_bb0020","first-page":"1","article-title":"Rapid implementation of service delivery changes to mitigate COVID-19 and maintain access to methadone among persons with and at high-risk for HIV in an opioid treatment program","author":"Peavy","year":"2020","journal-title":"AIDS & Behavior"},{"key":"10.1016\/j.jsat.2020.108219_bb0025","series-title":"Federal Guidelines for opioid treatment programs","author":"Substance Abuse and Mental Health Services Administration","year":"2015"},{"key":"10.1016\/j.jsat.2020.108219_bb0030","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.jsat.2020.108219_bb0035","series-title":"Opioid treatment program (OTP) guidance","author":"Substance Abuse and Mental Health Services Administration","year":"2020"},{"issue":"14","key":"10.1016\/j.jsat.2020.108219_bb0040","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1080\/10826084.2019.1653324","article-title":"Patient barriers and facilitators to medications for opioid use disorder in primary care","volume":"54","author":"Tofighi","year":"2019","journal-title":"Substance Use and Misuse"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547220304761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547220304761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:53:09Z","timestamp":1760039589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547220304761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":8,"alternative-id":["S0740547220304761"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2020.108219","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2020.108219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108219"}}